Collplant Biotechnologies

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Revenue
$249
$98
$299
$43
Gross Profit
-287
-727
-474
-235
EBITDA
-4,145
-4,049
-4,330
EBIT
-4,406
-4,329
-4,602
Net Income
-4,210
-4,195
-4,689
-4,377
Net Change In Cash
249
98
299
43
Free Cash Flow
-4,130
-3,335
-2,574
6,533
Cash
18,920
23,464
26,674
28,981
Basic Shares
11,454
11,453
11,452
11,443

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$10,959
$299
$15,641
$6,137
Gross Profit
8,968
-101
13,636
3,135
EBITDA
-6,410
-16,021
838
-4,939
EBIT
-7,512
-17,097
65
-5,599
Net Income
-7,019
-16,753
409
-5,808
Net Change In Cash
10,959
299
15,641
6,137
Free Cash Flow
-3,717
-15,014
912
-4,970
Cash
26,674
29,653
13,148
3,333
Basic Shares
11,389
11,033
11,966
6,886

Earnings Calls

Quarter EPS
2024-06-30
-$0.37
2024-03-31
-$0.37
2023-12-31
-$0.24
2023-09-30
-$0.38